News

Press Releases

BlueRock Therapeutics to Participate at Upcoming Conferences
November 11, 2018
BlueRock Therapeutics President and CEO Emile Nuwaysir elected to serve as Vice Chairman of the Alliance for Regenerative Medicine
October 3, 2018
BlueRock Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa
October 1, 2018
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
September 20, 2018
BlueRock Therapeutics Establishes R&D Site in New York City and Formalizes Collaboration with Memorial Sloan Kettering Cancer Center
April 17, 2018
BlueRock Therapeutics Announces Appointment of Derek Hei, Ph.D. as Senior Vice President, Manufacturing, Quality and Regulatory
December 1, 2017
BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors
November 1, 2017
BlueRock Therapeutics Establishes Corporate Headquarters in Cambridge, Massachusetts and Bolsters Team to Support Rapid Growth and Development
October 26, 2017
BlueRock Therapeutics and Universal Cells Enter Collaboration and License Agreement to Generate Gene-Edited iPS Cell Lines
October 3, 2017
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
August 17, 2017
BlueRock Therapeutics Announces Key Members of Executive Team
June 27, 2017
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
December 12, 2016

In the News

Bloomberg Canada - Stem Cells Meet AI in Quest to Mass-Produce Key Disease Fighters
December 12, 2017
WSJ Pro VC - Heavily Funded BlueRock Therapeutics to Put Cell Therapies to the Test
December 1, 2017
STAT News - What will FDA’s new rules mean for legitimate stem cell treatments?
November 22, 2017
BioCentury - FDA Unveils Regenerative Medicine Policy Framework
November 16, 2017
BetaKit - BlueRock Therapeutics Opens R&D and Manufacturing Hub in Toronto
August 17, 2017
Bloomberg TV - Helping to heal heart attacks using stem cells
August 17, 2017
WSJ Pro VC - Gormley’s Take: Cell Therapy Drawing Big Bets
June 30, 2017
BioCentury - Starting Up Stem Cells
December 22, 2016
Xconomy - BlueRock Raises $225M To Repair Heart Damage With Stem Cells
December 12, 2016
Fierce Biotech - Bayer, Versant join forces on $225M Series A for stem cell upstart
December 12, 2016
Boston Globe - Flush with $225 million, stem cell startup BlueRock considers Boston for research site
December 12, 2016
The Globe and Mail - Bayer investing in Toronto-based stem-cell research company
December 9, 2016

Media Contact

David Schull or Maggie Beller
Russo Partners, LLC
(646) 942-5631
Maggie.beller@russopartnersllc.com

Contact Us

Over the next 12 months, BlueRock will be significantly expanding staff at all locations. Contact us to learn about our rewarding career opportunities in New York, Boston/Cambridge, and Toronto.

Toronto, ON
BlueRock Toronto
MaRS Discovery District
101 College Street, East Tower, 15-701 Toronto, ON
M5G 1L7, Canada

New York, NY
BlueRock New York
Alexandria Center for Life Science
450 E 29th Street, Suite 504
New York, NY 10016, USA

Cambridge, MA
BlueRock Corporate Headquarters
1 Broadway
Cambridge, MA 02142, USA

News

Press Releases

In the News

Media Contact

Contact Us

Receive Corporate Updates